Moreover, oncolytic viruses can also be genetically modified to include therapeutic genes, cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-12, and play a synergistic role in killing tumor cells through multiple pathways, which can effectively avoid the current single-target anticancer drugs. This evidence concerns the gene CSF2 and neoplasm.